1. Clinical features of pulmonary arterial hypertension in patients receiving dasatinib. Issue 11 (12th October 2015) Authors: Shah, Neil P.; Wallis, Nicola; Farber, Harrison W.; Mauro, Michael J.; Wolf, Robert A.; Mattei, Daniele; Guha, Mausumee; Rea, Delphine; Peacock, Andrew Journal: American journal of hematology Issue: Volume 90:Issue 11(2015:Nov.) Page Start: 1060 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: the DASFREE study. Issue 3 (23rd February 2020) Authors: Shah, Neil P.; García-Gutiérrez, Valentín; Jiménez-Velasco, Antonio; Larson, Sarah; Saussele, Susanne; Rea, Delphine; Mahon, François-Xavier; Levy, Moshe Yair; Gómez-Casares, María Teresa; Pane, Fabrizio; Nicolini, Franck-Emmanuel; Mauro, Michael J.; Sy, Oumar; Martin-Regueira, Patricia; Lipton, ... Journal: Leukemia & lymphoma Issue: Volume 61:Issue 3(2020) Page Start: 650 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dasatinib in imatinib‐resistant or ‐intolerant chronic‐phase, chronic myeloid leukemia patients: 7‐year follow‐up of study CA180‐034. Issue 9 (20th June 2016) Authors: Shah, Neil P.; Rousselot, Philippe; Schiffer, Charles; Rea, Delphine; Cortes, Jorge E.; Milone, Jorge; Mohamed, Hesham; Healey, Diane; Kantarjian, Hagop; Hochhaus, Andreas; Saglio, Giuseppe Journal: American journal of hematology Issue: Volume 91:Issue 9(2016:Sep.) Page Start: 869 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dasatinib plus Peg‐Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA‐PegIFN study). (10th October 2022) Authors: Roy, Lydia; Chomel, Jean‐Claude; Guilhot, Joëlle; Guerci‐Bresler, Agnès; Escoffre‐Barbe, Martine; Giraudier, Stéphane; Charbonnier, Aude; Dubruille, Viviane; Huguet, Françoise; Johnson‐Ansah, Hyacinthe; Lenain, Pascal; Ame, Shanti; Etienne, Gabriel; Nicolini, Franck E.; Rea, Delphine; Cony‐Makhou... Journal: British journal of haematology Issue: Volume 200:Number 2(2023) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity. Issue 5 (6th October 2016) Authors: Riou, Marianne; Seferian, Andrei; Savale, Laurent; Chaumais, Marie-Camille; Guignabert, Christophe; Canuet, Matthieu; Magro, Pascal; Rea, Delphine; Sitbon, Olivier; Jaïs, Xavier; Humbert, Marc; Montani, David Journal: European respiratory journal Issue: Volume 48:Issue 5(2016) Page Start: 1517 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group. Issue 14 (3rd May 2018) Authors: Rea, Delphine; Ame, Shanti; Berger, Marc; Cayuela, Jean‐Michel; Charbonnier, Aude; Coiteux, Valérie; Cony‐Makhoul, Pascale; Dubruille, Viviane; Dulucq, Stéphanie; Etienne, Gabriel; Legros, Laurence; Nicolini, Franck; Roche‐Lestienne, Catherine; Escoffre‐Barbe, Martine; Gardembas, Martine; Guerci‐... Journal: Cancer Issue: Volume 124:Issue 14(2018) Page Start: 2956 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Final analysis of the efficacy and safety of omacetaxine mepesuccinate in patients with chronic‐ or accelerated‐phase chronic myeloid leukemia: Results with 24 months of follow‐up. Issue 10 (13th January 2015) Authors: Cortes, Jorge E.; Kantarjian, Hagop M.; Rea, Delphine; Wetzler, Meir; Lipton, Jeffrey H.; Akard, Luke; Khoury, H. Jean; Michallet, Mauricette; Guerci‐Bresler, Agnès; Chuah, Charles; Hellmann, Andrzej; Digumarti, Raghunadharao; Parikh, Purvish M.; Legros, Laurence; Warzocha, Krzysztof; Baccarani, ... Journal: Cancer Issue: Volume 121:Issue 10(2015) Page Start: 1637 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. How I manage relapse of chronic myeloid leukaemia after stopping tyrosine kinase inhibitor therapy. (19th October 2017) Authors: Rea, Delphine; Mahon, François‐Xavier Journal: British journal of haematology Issue: Volume 180:Number 1(2018) Page Start: 24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy. Issue 10 (31st August 2018) Authors: Racil, Zdenek; Koritakova, Eva; Sacha, Tomasz; Klamova, Hana; Belohlavkova, Petra; Faber, Edgar; Rea, Delphine; Malaskova, Ludmila; Prochazkova, Jirina; Zackova, Daniela; Voglova, Jaroslava; Wącław, Joanna; Cetkovsky, Petr; Zak, Pavel; Mayer, Jiri Journal: American journal of hematology Issue: Volume 93:Issue 10(2018:Oct.) Page Start: E342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia. Issue 6 (6th December 2020) Authors: Fontana, Diletta; Ramazzotti, Daniele; Aroldi, Andrea; Redaelli, Sara; Magistroni, Vera; Pirola, Alessandra; Niro, Antonio; Massimino, Luca; Mastini, Cristina; Brambilla, Virginia; Bombelli, Silvia; Bungaro, Silvia; Morotti, Alessandro; Rea, Delphine; Stagno, Fabio; Martino, Bruno; Campiotti, Leo... Journal: HemaSphere Issue: Volume 4:Issue 6(2020) Page Start: e497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗